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Abstract
Saccharomyces cerevisiae Rad9 is required for an effective DNA damage response throughout the cell cycle. Assembly of
Rad9 on chromatin after DNA damage is promoted by histone modifications that create docking sites for Rad9 recruitment,
allowing checkpoint activation. Rad53 phosphorylation is also dependent upon BRCT-directed Rad9 oligomerization;
however, the crosstalk between these molecular determinants and their functional significance are poorly understood. Here
we report that, in the G1 and M phases of the cell cycle, both constitutive and DNA damage-dependent Rad9 chromatin
association require its BRCT domains. In G1 cells, GST or FKBP dimerization motifs can substitute to the BRCT domains for
Rad9 chromatin binding and checkpoint function. Conversely, forced Rad9 dimerization in M phase fails to promote its
recruitment onto DNA, although it supports Rad9 checkpoint function. In fact, a parallel pathway, independent on histone
modifications and governed by CDK1 activity, allows checkpoint activation in the absence of Rad9 chromatin binding.
CDK1-dependent phosphorylation of Rad9 on Ser11 leads to specific interaction with Dpb11, allowing Rad53 activation and
bypassing the requirement for the histone branch.
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Introduction
The DNA damage checkpoint coordinates cell cycle progres-
sion, DNA repair, replication, recombination, apoptosis and
senescence in response to genotoxic stress. Defects in this
surveillance mechanism lead to increased genomic instability,
cancer susceptibility, ageing and several human pathologies [1,2].
The checkpoint is organized as a signal transduction cascade,
whose players have been conserved throughout evolution [3,4].
When DNA is damaged, cells are able to sense and process the
lesions generating a series of phosphorylation events, which are
then amplified and propagated to specific targets [3,4]. Critical
checkpoint factors are phosphorylated in response to DNA
damage and their order of functions in the cascade has been
mainly inferred by monitoring their phosphorylation state [5]. The
apical kinases in the pathway are members of a family of
phosphatidylinositol 39 kinase-like kinases (PIKKs), which includes
Mec1 and Tel1 from budding yeast, as well as mammalian ATM,
ATR and DNA-PK [6]. In the yeast Saccharomyces cerevisiae the first
biochemical event in response to checkpoint activation is the
Mec1-dependent phosphorylation of its interacting subunit Ddc2
[7–9]. Other critical Mec1 targets are histone H2A, the 9-1-1
complex and the Rad9 mediator which is necessary for the
recruitment and activation of the main effector kinase Rad53
[10–16]. Rad53 phosphorylation is a key step in the signal
transduction cascade and it is generally used as a marker to
monitor full checkpoint activation [17].
In a pioneering study, RAD9 was the first DNA damage
checkpoint gene identified in yeast and it is required for proper
DNA damage response in all cell cycle phases and in response to a
variety of genotoxins [18–20]. Rad9 is a large protein of 148 kDa
containing a tandem repeat of the BRCT (BRCA1 C-terminus)
motif, which is required for Rad9 oligomerization and function
[21–23]. Until recently the biochemical role of the RAD9 gene
product remained obscure. Gilbert et al., were the first to purify
Rad9 complexes from undamaged and UV-treated cells; structural
characterization of such complexes led to the proposal that Rad9
recruits and catalyzes the activation of Rad53, by acting as a
scaffold protein bringing Rad53 molecules in close proximity, thus
facilitating the Rad53 autophosphorylation reaction [14].
The Rad9 protein contains several potential target sites for
CDK1/Cdc28 kinase and PIKK-directed phosphorylation [24].
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hyper-phosphorylated in a Mec1- and/or Tel1-dependent manner
after genotoxic treatments [12,13]. This hyper-phosphorylation is
a pre-requisite for Rad9-Rad53 association, which is mediated by
the two forkhead associated (FHA) Rad53 domains and specific
Rad9 amino acid residues that are modified in the hyper-
phosphorylated Rad9 form [12,13,15,16,25–27]. Recent data
confirmed that the Rad9 BRCT domains mediate Rad9
oligomerization, and these interactions are also modulated by
Mec1/Tel1-dependent phosphorylation of a SQ/TQ cluster
domain (SCD) in Rad9. Rad9 oligomerization is required to
maintain checkpoint signaling through a feedback loop involving
Rad53-dependent phosphorylation of the Rad9 BRCT domains,
which attenuates BRCT-SCD interactions [27].
Despite the fundamental nature of the cellular response to DNA
damage, Rad9 and its Schizosaccharomyces pombe and metazoan
orthologs Crb2 and 53BP1 show a modest level of amino acid
sequence conservation. Dimerization mediated by the BRCT
domains has been shown to be essential for the biological function
of both Rad9 and Crb2 [21,28], however, 53BP1 oligomerization
occurs in a BRCT-independent manner [29,30]. Recent structural
analysis showed that an equivalent surface is conserved to a certain
degree also in 53BP1 and it provides the binding site for p53. It
was thus suggested that a functional requirement for dimerization
of a checkpoint mediator may have been conserved in the
evolution, but in metazoan organisms it may be delivered via a
second protein rather than through homotypic interactions [31].
In the last few years it became evident that chromatin
remodelling activities and post-translational modifications of
chromatin components, including histones, influence DNA
damage checkpoint signalling and repair in all eukaryotic cells
(see [32] for a recent review). Moreover, it has been recently
suggested that Rad9 may also be chromatin-bound in the absence
of DNA damage [22]. This dynamic interaction with chromatin
appears to require the Tudor domain of Rad9 and methylated
lysine 79 of histone H3 (H3-K79me). Furthermore, this interaction
modulates Rad9 functions after DNA damage [22,23,33–35].
However, the Crb2 and 53BP1 orthologues of Rad9 both
recognize H4 methylated at lysine 20 (H4-K20me), although
human 53BP1 may also be recruited to chromatin through
interactions with H3-K79me [34,36–39].
For the Rad9/Crb2/53BP1 mediator proteins, efficient recruit-
ment seems to require additional molecular interactions. Rad9 and
Crb2 interact via their BRCT domains with H2A phosphorylated at
serine 129 (cH2A) at sites of DNA damage [22,31,37,40–42]. 53BP1
binding to DSBs is facilitated by phosphorylation of serine 139 of the
histone variant H2AX (cH2AX) [29,43–45]. It has been reported
that various oligomerization domains in 53BP1 facilitate its
recruitment to damaged DNA sites [30]. Moreover, 53BP1
recruitment to chromatin is facilitated by ubiquitination of H2A
and H2AX by RNF8 through a yet unidentified mechanism [46–48].
Recently, it has been shown that Dpb11 in S. cerevisiae and its S.
pombe and metazoan orthologs, termed Rad4/Cut5 and TopBP1,
respectively, are required for full PIKK-dependent checkpoint
activation in response to DNA damage [49,50]. Moreover it has
been suggested that Dpb11 orthologs may modulate checkpoint
activation through interaction with mediator/adaptor proteins
[37,51]. To explore the functional role and the relationship
between the BRCT domains and Rad9 ability to bind chromatin,
we have analyzed both Rad9 chromatin recruitment and
checkpoint activation in cells engineered to express various forms
of Rad9 harboring mutated BRCT domains, including point
mutations, deletion and substitutions with heterologous dimeriza-
tion domains. We found that the requirements for Rad9 binding to
chromatin are different in G1 or in M phase cells and in damaging
versus unperturbed conditions. Moreover, we tested the require-
ments for Rad9 chromatin binding in yeast mutants defective in
either the histone-dependent and/or histone-independent path-
ways essential for full checkpoint activation in M phase.
Importantly, we found that CDK1-dependent Rad9 phosphory-
lation on Ser11 modulates the Dpb11-dependent branch in the M
phase of the cell cycle in a chromatin-independent manner.
Results
Rad9 BRCT domains are required for its binding to
chromatin in unperturbed and DNA damaging
conditions
The Rad9 checkpoint mediator protein contains a tandem
repeat of the BRCT motif at its C-terminus. Previous experiments
have shown that the BRCT domains are critical for the activation
of the DNA damage checkpoint and two-hybrid and GST pull-
down analysis indicated that the BRCT domains modulate Rad9-
Rad9 interactions [21]. More recently, it has been shown that
Rad9 mutations in a conserved region of the first BRCT motif
affect binding to cH2A, thus altering the G1 checkpoint signaling
in response to DSBs [22,40] and the G2/M response to uncapped
telomeres [23]. However, the mutations analyzed did not influence
Rad9 chromatin binding in unperturbed conditions [22].
The rad9-F1104L or the rad9-W1280L mutations substitute the
most highly conserved amino acid residues in the two BRCT
motifs and each mutation affects productive Rad9-Rad9 interac-
tions [21]. We tested whether such rad9 mutations impair Rad9
recruitment to chromatin both in unperturbed and DNA
damaging conditions. As expected, a proportion of wild-type
Rad9 migrated much more slowly under our gel running
conditions after UV treatment, consistent with hyper-phosphory-
lation of Rad9 (Figure 1A). A relevant fraction of Rad9 was found
associated to chromatin in the absence of DNA damage, both in
G1- and in M-arrested cells, confirming previous observations
[22]. Control experiments were routinely performed to verify the
distribution of standard protein markers in the soluble and
Author Summary
In response to DNA damage all eukaryotic cells activate a
surveillance mechanism, known as the DNA damage
checkpoint, which delays cell cycle progression and
modulates DNA repair. Yeast RAD9 was the first DNA
damage checkpoint gene identified. The genetic tools
available in this model system allow to address relevant
questions to understand the molecular mechanisms
underlying the Rad9 biological function. By chromatin-
binding and domain-swapping experiments, we found
that Rad9 is recruited into DNA both in unperturbed and in
DNA–damaging conditions, and we identified the molec-
ular determinants required for such interaction. Moreover,
the extent of chromatin-bound Rad9 is regulated during
the cell cycle and influences its role in checkpoint
activation. In fact, the checkpoint function of Rad9 in G1
cells is solely mediated by its interaction with modified
histones, while in M phase it occurs through an additional
scaffold protein, named Dpb11. Productive Rad9-Dpb11
interaction in M phase requires Rad9 phosphorylation by
CDK1, and we identified the Ser11 residue as the major
CDK1 target. The model of Rad9 action that we are
presenting can be extended to other eukaryotic organ-
isms, since Rad9 and Dpb11 have been conserved through
evolution from yeast to mammalian cells.
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consistently found that the ratio of hyper- to hypo-phosphorylated
Rad9 was approximately constant in both the soluble and
chromatin fractions in G1 cells. Interestingly, in M phase cells,
hyper-phosphorylated Rad9 was mostly present in the soluble
fraction, while chromatin was enriched in the hypo-phosphory-
lated form (Western blot quantitation are shown in Figure S1C).
As shown in Figure 1A, any of the two BRCT mutations abolished
Rad9 phosphorylation and recruitment to chromatin in G1- or M-
arrested cells. As expected [21], rad9-F1104L and rad9-W1280L
mutant cells were highly sensitive to UV treatments (Figure 1B).
These results indicate that BRCT domains influence not only
Rad9 binding to chromatin by modulating its interaction with
cH2A after DNA damage [22], but they also control Rad9
recruitment to chromatin in unperturbed conditions.
A heterologous dimerization domain restores Rad9
binding to chromatin in G1-arrested, but not M-arrested,
cells
To further evaluate the relevance of Rad9-Rad9 interactions in
chromatin binding, we generated a set of yeast strains in which the
C-terminal region of Rad9, containing the BRCT motifs, was
substituted with either a 13-MYC epitope or a GST tag (see
Materials and Methods). The latter has been shown to act as a
heterologous constitutive dimerization domain [28,52,53].
As shown in Figure 2A, the GST tag was capable of driving,
albeit somewhat less efficiently, Rad9 chromatin binding in G1-
arrested cells, both in the absence or presence of DNA damage.
Importantly, Rad9DBRCT::GST recruitment to chromatin still
occurs through its interaction with H3-K79me, as it was drastically
reduced in a dot1D background, lacking the specific H3-K79
histone methyl-transferase. Rad9 dimerization through the GST
tag also significantly recovered Rad9 hyper-phosphorylation after
UV irradiation and full checkpoint function (Figure 2A and data
not shown).
It must be underlined that addition of the GST tag to
Rad9DBRCT, allowing Rad9 dimerization, reconstitutes chroma-
tin binding even though Rad9DBRCT::GST lacks the BRCT
tandemrepeatsandis,therefore,unable to interact with cH2A[22].
These authors suggested that, after DNA damage, Rad9 shifts from
H3-K79me to phosphorylated H2A-S129, and this translocation
would be deficient in rad9DBRCT::GST cells. As a consequence of its
defective interaction with cH2A, binding of Rad9DBRCT::GST to
chromatin is probably much less stable. This hypothesis may
explain the finding that in the rad9DBRCT::GST strain the majority
of phosphorylated Rad9 after UV irradiation in G1 is found in the
soluble fraction (Figure 2A).
To further support the role of Rad9 dimerization in its chromatin
binding in G1-arrested cells solely by inducing Rad9-Rad9
interactions, we tested the possibility to direct a Rad9DBRCT
isoform to chromatin by adding to the truncated protein a FKBP
Figure 1. Rad9 chromatin binding requires an intact BRCT domains in UV–treated and in unperturbed conditions. (A) wt (K699), rad9-
F1104L (YNOV15), rad9-W1280L (YNOV31) strains were arrested in G1 with a-factor or in M with nocodazole and either mock or UV irradiated (75 J/
m
2). 10 min after irradiation, samples were collected and analyzed in their total (T), soluble (S) and chromatin-enriched (Ch) fractions. Blots were
probed with anti-Rad9 antibodies and, after staining, the blots were cut to eliminate the Rad9-unrelated protein species migrating adjacent to the
hyper-phosphorylated Rad9 isoform (Figure S1A). The positions of Rad9 and its hyper-phosphorylated isoform (pRad9) are indicated. (B) The same
yeast strains analyzed in A and a rad9D strain (YMAG88) were grown overnight to log phase and serial dilutions were spotted onto YPD plates, which
were then irradiated at the indicated UV doses and incubated for 3 days.
doi:10.1371/journal.pgen.1001047.g001
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molecule AP20187 [54]. Indeed, the presence of the FKBP tag
partially rescued Rad9 chromatin binding in G1-arrested cells, but
only in the presence of inducing AP20187 (Figure 2B). Importantly,
addition of the dimerization inducing molecule fully recovered the
UV sensitivity of rad9DBRCT cells (Figure 2C).
Contrary to our observations in G1-arrested cells, the
heterologous GST dimerization domain did not rescue Rad9
binding to chromatin in nocodazole-arrested cells, although it
restored checkpoint activation after DNA damage (Figure 2D,
Figure 3A). Rad9 missing the BRCT domains only exhibits partial
phosphorylation; this form can be distinguished from the hyper-
phosphorylated isoform due to different electrophoretic mobility
and its incapacity to activate Rad53 (see Figure 3A).
Altogether, the findings reported above indicate that dimeriza-
tion is required for Rad9 to bind H3-K79me in G1-arrested cells,
both with and without an exogenous DNA damaging agent.
However, this is not the case in M phase-arrested cells, where
GST-directed Rad9 dimerization partially recovers genotoxin-
induced Rad9 hyper-phosphorylation, but fails to rescue its
binding to chromatin. This may suggest that, at least in M phase,
Rad9 chromatin binding is not directly linked to Rad9 hyper-
phosphorylation.
GST-driven Rad9 dimerization rescues checkpoint
activation and UV–sensitivity, despite undetectable
chromatin binding
Although the addition of a heterologous dimerization domain
to truncated Rad9DBRCT was not able to allow Rad9
chromatin binding in M phase-arrested cells, it rescues Rad53
activation after UV irradiation. In fact, as shown in Figure 3A,
the phosphorylation state of the effector checkpoint kinase,
Rad53, was found to be very different after UV-irradiation of
rad9DBRCT::GST or rad9DBRCT::13MYC cells arrested with
nocodazole. The hyper-phosphorylated form of Rad53 is absent
in UV treated rad9DBRCT::13MYC cells, while it is clearly
detectable in rad9DBRCT::GST cells. Although the extent of
Figure 2. GST-driven Rad9 dimerization recovers its binding to chromatin in G1, but not in M phase. (A) wt (K699), rad9DBRCT::13MYC
(YFL696/1b), rad9DBRCT::GST (YMAG74) and rad9DBRCT::GST dot1D (YFL773/2c) cells were arrested in G1 with a-factor and either mock or UV
irradiated (75 J/m
2). After 10 min, samples were collected and analyzed in their total (T), soluble (S) and chromatin-enriched (Ch) fractions. Blots were
probed with anti Rad9 antibodies as in the legend to Figure 1A. (B) wt (K699) and rad9DBRCT::FKBP (YFL901) cells were incubated for 6 h in the
presence or in the absence of the dimerization-inducing molecule AP20187, blocked in G1 with a-factor and analyzed in their total (T), soluble (S) and
chromatin-enriched (Ch) fractions. Blots were probed with anti Rad9 antibodies. (C) The same strains as in B were grown overnight to log phase and
incubated for 6 h in the presence or in the absence of the dimerization-inducing molecule AP20187. Serial dilutions were spotted onto YPD plates,
which were then irradiated at the indicated UV doses and incubated for 3 days. (D) Western blot analysis of the total, soluble and chromatin-enriched
fractions from wt (K699), rad9DBRCT::13MYC (YFL696/1b) and rad9DBRCT::GST (YMAG74) cells arrested in M phase and either mock or UV irradiated
(75 J/m
2). In all panels, the positions of Rad9 and its hyper-phosphorylated isoform (pRad9) are indicated. p* marks a partially phosphorylated Rad9
species.
doi:10.1371/journal.pgen.1001047.g002
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relative to wild-type cells, the presence of the heterologous
GST dimerization domain recovers the Rad9 checkpoint
function, as confirmed by a direct checkpoint assay (data not
shown). This conclusion is also supported by the observation
that addition of the GST tag significantly rescued, although not
completely, the UV sensitivity of the rad9DBRCT::13MYC strain
( F i g u r e3 B ) ,a n dt h e s ef i n d i n g sa re in agreement with previous
experiments in S.pombe [28].
Thus far our data indicate that dimerization of Rad9 directed
by an heterologous domain confers activation of the DNA damage
checkpoint cascade, as well as significant resistance to UV in M
phase-arrested cells, despite undetectable binding of Rad9 to
chromatin (see Figure 2D).
Checkpoint activation in M phase requires CDK1 activity
and is driven by Rad9–Dpb11 interaction
We have recently demonstrated that in the M phase of the cell
cycle, full activation of the DNA damage checkpoint in response to
various genotoxic stress is dependent upon Dpb11 [50]. Our data
suggested that Dpb11 facilitates the recruitment of Rad9
proximally to DNA lesions through a mechanism independent of
histone modifications. Indeed, as shown in Figure 4A, checkpoint
activation after UV irradiation of nocodazole-arrested cells is only
partially affected either in dot1D or in dpb11DCT cells. On the
other hand, dot1D dpb11DCT double mutant cells are dramatically
deficient in Rad53 phosphorylation since both the histone-
dependent and histone-independent pathways for checkpoint
activation are not functional. This finding can be interpreted by
hypothesizing that when Rad9 cannot bind to chromatin via
histone marks, Dpb11 may act as a platform for Rad9 recruitment
in a histone-independent manner. Moreover, because the Dpb11-
dependent pathway is particularly relevant in the G2 to M phases
of the cell cycle [50], it was tempting to hypothesize that the
proposed interaction between Rad9 and Dpb11 might be
regulated by cell cycle-dependent control mechanisms [55].
Initially, we monitored this interaction using two-hybrid analysis
performed at different cell cycle stages (see Materials and
Methods). As shown in Figure 4B, a strong Rad9-Dpb11
interaction was observed in nocodazole-arrested cells. Several
independent two-hybrid experiments showed that Rad9-Dpb11
interaction was more evident in M- rather than in G1-arrested
cells. Experiments performed with a bait and a prey already
known to interact by two-hybrid, indicate that the M/G1 ratio of
Rad9-Dpb11 interaction was significantly higher than that found
in the controls, suggesting a cell cycle-specific effect (Figure S2A).
The Rad9-Dpb11 interaction was further confirmed biochemically
(see below).
Since the interaction between Rad9 and Dpb11 appears to be
induced in M phase, we reasoned that the Dpb11-dependent
branch of the DNA damage checkpoint in M phase might be
related to the increasing level of CDK1 kinase activity as cells
move through the S, G2 and M phases of the cell cycle. To
address this issue, we took advantage of the cdc28-as1 mutant (in
which only the Cdc28 kinase is specifically sensitive to bulky ATP
analogues, such as 1NMPP1 [56]) to conditionally inactivate
CDK1 in nocodazole-treated cells. Cdc28 kinase activity was
inhibited or not with 1NMPP1 in nocodazole arrested cells and
mitotic cells were then mock- or UV irradiated to induce DNA
damage. Western blot analysis of Rad53 revealed that CDK1
inhibition abolished phosphorylation of Rad53 in the absence of
the histone-dependent pathway, while no effect was observed in
DOT1 cells (Figure 4C). A similar experiment was performed by
tethering checkpoint factors to DNA in the absence of damage
[57]. The difference between our result and that reported by
Bonilla, may be explained if, in their experimental conditions,
without the addition of genotoxic agents, checkpoint activation is
independent upon the Dpb11 branch.
Figure 3. GST-driven Rad9 dimerization allows M checkpoint function regardless of Rad9 chromatin binding. (A) wt (K699),
rad9DBRCT::13MYC (YFL696/1b), rad9DBRCT::GST (YMAG74) cells were cultured to mid-log phase, arrested in M with nocodazole, and either mock or
UV irradiated (75 J/m
2); 10 min after irradiation, Rad53 phosphorylation was analyzed by SDS-PAGE and Western blotting with polyclonal Rad53
antibodies and with the F9 monoclonal antibody (Mab) recognizing only the hyper-phosphorylated active form of Rad53 to monitor checkpoint
activation. (B) The same cells analyzed in A and a rad9D control strain (YMAG88) were cultured overnight, diluted and plated on YPD plates, which
were irradiated with the indicated UV doses. Cell survival was assayed by determining the number of colonies grown on plates after 2 days; error bars
were obtained from 3 independent experiments.
doi:10.1371/journal.pgen.1001047.g003
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for the function of the histone-independent branch necessary for
Rad53 phosphorylation in cells arrested in mitosis.
CDK1-dependent phosphorylation of serine 11 of Rad9
modulates the Dpb11-dependent branch in M phase
cells
Rad9 contains 20 potential (SP or TP) target sites for CDK-
dependent phosphorylation, 9 of which conform to the canonical
CDK phosphorylation site (S/T-P-x-K/R) (Figure S2B). We
hypothesized that Rad9 could be a relevant CDK1 target in the
histone-independent branch of the DNA damage checkpoint in M
phase cells. Initially, we tested a rad9DNT mutant strain, in which
the first 231 amino acids, including 9 S/T-P sites, of Rad9 are
missing (Materials and Methods and [58]). As shown in Figure 5A,
Rad53 phosphorylation was partially defective in both dot1D and
rad9DNT mutants and essentially abolished in a rad9DNT dot1D
double mutant strain.
All 9 potential Cdc28 phosphorylation sites in the Rad9 N-
terminal region were individually mutagenized and different
mutant combinations tested (Materials and Methods and data
not shown). rad9-S11A cells displayed a detectable defect in cell
cycle-regulated Rad9 phosphorylation (Figure S2C). Moreover,
the rad9-S11A mutation recapitulates the phenotype we observed
in rad9DNT cells, namely, severe loss of DNA damage-dependent
Rad53 phosphorylation when combined with dot1D (Figure 5B).
Consistently, the rad9-S11A mutation alone did not confer a strong
sensitivity to UV irradiation (Figure 5C), while a rad9-S11A dot1D
double mutant strain was synthetically sensitive to genotoxic
treatment. On the other hand, a rad9-S11A dpb11DCT double
mutant strain did not exhibit an increased sensitivity to UV
irradiation when compared to strains harboring the single
mutations, indicating that Dpb11 and Rad9-S11 phosphorylation
act in the same pathway (data not shown). Phosphorylation of
Rad9S11 has been reported in vivo [59]. In order to verify the
relevance of S11 phosphorylation in our experimental conditions,
we reverted the S11A mutation to Thr, another phosphorylatable
residue. Figure 5D shows that Rad9 carrying a Thr at position 11
rescues the phenotype imparted by the S11A mutation, since
checkpoint activation in the rad9-S11T dot1D strain is identical to
that found in dot1D cells.
Interestingly, Rad9-Dpb11 interaction by two-hybrid analysis
was reduced when the Rad9NT isoform, lacking the 9 potential
CDK1 phosphorylation sites, was used as a prey in a wild-type
background, or when Cdc28 activity was inhibited by 1NMPP1
addition in the cdc28-as1 strain (Figure 6A). The in vivo interaction
between Rad9 and Dpb11 was also confirmed by co-immupre-
cipitation of the endogenous proteins after genotoxic treatment. As
shown in Figure 6B, immunoprecipitation of MYC-tagged Dpb11
recovers the hyper-phosphorylated isoform of Rad9, and this
interaction is virtually lost in the rad9-S11A mutant strain
(Figure 6C). We also noticed that the Rad9-S11A mutant protein
has slighlty less gel-mobility than its wild type counterpart, as
shown in Figure 6C. This observation can be explained by either a
mild defect in Mec1/Tel1-dependent hyperphosphorylation of the
Rad9-S11A protein, due to the loss of Rad9-Dpb11 interaction, or
a direct effect of the S11A mutation which, affecting CDK1-
dependent phosphorylation of Rad9, may directly modify its
migration in SDS PAGE.
Altogether, the above findings indicate that the Ser11 CDK1-
consensus site on Rad9 is a relevant target to modulate Rad9-
Dpb11 interaction and the CDK1-dependent checkpoint response
in M phase cells.
Figure 4. A cell cycle–dependent interaction between Dpb11
and Rad9 may regulate the Dpb11-dependent pathway. (A) wt
(YMAG149/7B), dpb11DCT (YMAG145/20C), dot1D (YMAG150/4A) and
dpb11DCT dot1D (YMAG148) strains were arrested in M with nocodazole
and mock or UV irradiated (75 J/m
2). 10 min after irradiation, samples
were taken and protein extracts were separated by SDS-PAGE. Blots
were analyzed with anti Rad53 antibodies. (B) EGY42 cells, containing
the pSH18-34 b-galactosidase reporter plasmid, were transformed with
the Rad9 prey plasmid pMAG11.1 (pJG4-5-RAD9) and/or with the Dpb11
bait plasmid pFP15 (pEG202-DPB11). Strains were cultured overnight in
-His, -Trp, -Ura medium plus raffinose and arrested in M phase by
nocodazole treatment. Galactose was then added to the medium to
induce bait expression. A modified version of ONPG yeast two-hybrid
assay was used to determine the b-galactosidase activity in each strain,
expressed in relative units. (C) cdc28-as1 (JAU01) and cdc28-as1 dot1D
(YNOV4) strains were arrested in M with nocodazole and, after
incubation for 2 h in the absence or in the presence of 5 mM 1NMPP1,
were either mock or UV irradiated (75 J/m
2). After 10 min, samples were
collected and protein extracts were separated by SDS-PAGE. Blots were
analyzed with anti-Rad53 antibodies.
doi:10.1371/journal.pgen.1001047.g004
Rad9 Chromatin Binding and Checkpoint Activation
PLoS Genetics | www.plosgenetics.org 6 August 2010 | Volume 6 | Issue 8 | e1001047The Dpb11-dependent branch in M phase modulates
checkpoint activation in a chromatin-independent
manner
To gain further insights into the mechanisms involving Rad9
and the Dpb11-dependent branch of the DNA damage checkpoint
operating in nocodazole-arrested cultures, cell extracts were
fractionated into soluble and chromatin fractions. Specifically,
we monitored Rad9 chromatin binding and Rad53 phosphoryla-
tion in strains harbouring defects in the different branches known
to regulate Rad9 checkpoint functions during M phase.
As shown in Figure 7, following DNA damage, the Dpb11 C-
terminal region carrying the BRCT domain does not appear to be
required for Rad9 binding to chromatin, as dpb11DCT cells
behave as wild type. However, as expected, Rad9 chromatin
recruitment is defective in dot1D and H2A-S129A mutant cells, as
binding of Rad9 is dependent upon H3-K79me and cH2A, via its
Tudor and BRCT domains respectively [22,34,60]. Checkpoint
activation, as determined by Rad53 phosphorylation, was
abolished in any double or triple mutant combinations carrying
the dpb11DCT mutation (Figure 7). Intriguingly, even when
detectable Rad9 binding to chromatin is abrogated (as in the
single dot1D and H2A-S129A or in the double dot1D H2A-S129A
mutant strains) Rad53 can be fully phosphorylated. Similar genetic
dependencies were found when the various single, double and
triple mutant strains were tested for checkpoint activation in
response to zeocin treatment, which is known to cause DSBs
(Figure S3 and data not shown).
Dpb11 is responsible for checkpoint activation in M
phase cells when the Rad9 BRCT domains are replaced
with a heterologous dimerization domain
We have determined (Figure 3A) that in nocodazole-arrested
cells defective checkpoint activation due to the absence of the
Rad9 BRCT domain can be partially rescued by adding the GST
Figure 5. Phosphorylation of Rad9S11 by CDK1 is required for the establishment of an effective UV response in the absence of
Dot1. (A) wt (K699), dot1D (YFL234), rad9DNT (DLY2236) and rad9DNT dot1D (YFP91) strains were arrested with nocodazole and either mock or UV
irradiated (75 J/m
2). After 10 min samples were collected and protein extracts were separated by SDS-PAGE. Blots were analyzed with anti-Rad53 or
with the F9 Mab to monitor checkpoint activation. (B) wt (K699), dot1D (YFL234), rad9-S11A (YMAG162) and rad9-S11A dot1D (YMAG164) strains were
arrested in M, irradiated and Rad53 was detected by Western blotting as describe in panel A. (C) The same strains analyzed in B were cultured
overnight, diluted and plated on YPD plates, which were irradiated with the indicated UV doses. Cell survival was assayed as described in the legend
of Figure 3. (D) wt (K699), dot1D (YFL234), rad9-S11A dot1D (YMAG164) and rad9-S11T dot1D (YNOV52) strains were arrested with nocodazole and
either mock or UV irradiated (75 J/m
2). After 10 min samples were collected and protein extracts were separated by SDS-PAGE. Blots were analyzed
with anti-Rad53 or with the F9 Mab to monitor checkpoint activation.
doi:10.1371/journal.pgen.1001047.g005
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phase-specific DNA damage checkpoint contains a pathway
based on Rad9-Dpb11 interactions and modulated via phos-
phorylation of the Ser11 residue of Rad9 by CDK1 (Figure 4,
Figure 5, and Figure 6). As a consequence, we tested whether, in
nocodazole-arrested cells, checkpoint activation supported by the
heterologous dimerization motif in the rad9DBRCT::GST mutant
strain was dependent upon Dpb11. To address this question, we
introduced the S11A point mutation in the rad9DBRCT::GST
strain (rad9-S11ADBRCT::GST). Whilst either single mutant strain
was only partially defective in Rad53 phosphorylation, in rad9-
S11ADBRCT::GST cells, checkpoint activation was severely
impaired (Figure 8A). This result indicates that in
rad9DBRCT::GST cells residual checkpoint activation depends
upon an active Dpb11 branch acting through a potential CDK1
site (S11) in the amino terminus of Rad9. As expected, rad9-
S11ADBRCT::GST cells, in which the sole Rad9 expressed
contains both the point mutation and the domain swap, are
more sensitive to UV irradiation than either single mutant
(Figure 8B).
In conclusion, our data are consistent with the hypothesis that
Rad9 plays two independent roles in checkpoint activation: the
first mediated by its dimerization and binding to modified
histones, the second, which involves its phosphorylation by
CDK1 and interaction with Dpb11 (Figure 9).
Discussion
RAD9 was the first DNA damage checkpoint gene identified in
yeast [18]; however, the precise molecular details regarding the
role of the corresponding gene product, its function and regulation
remain far from being fully understood. In budding yeast, Rad9
seems to act as an adaptor protein in the signal transduction
checkpoint cascade, mediating the transmission of the signal from
the apical PIKKs to the main primary transducer kinase, Rad53
[27,61]. Rad9 phosphorylation, mediated by Mec1, is an early
event in the signal transduction cascade and this modification in
G1 is mainly influenced by histone H3 methylation [22,33,60,62].
In M phase, Rad9 phosphorylation also requires Dpb11, whose
role as an alternative scaffold for Rad9 activation has been
unveiled only recently [50]. The dynamics of Rad9 recruitment at
various cell cycle stages and the genetic dependencies controlling
Rad9 interaction with DNA/chromatin and other proteins are
largely unknown.
Figure 6. CDK1-dependent phosphorylation of S11-Rad9 modulates Rad9-Dpb11 interaction. (A) Two-hybrid interaction between
Dpb11 and Rad9 was tested in a wt (K699) (left) or in a cdc28-as1 (JAU01) (right) genetic background with the indicated bait and prey plasmids.
Where specified 5 mM 1NMPP1 was added to the media for 1 h before bait induction and extracts preparation. (B) The Dpb11-myc (YFP38) strain was
arrested with nocodazole and either mock treated or treated with 150 mg/ml of zeocin for 30 min. Whole cell protein extract was prepared and
tagged Dpb11-MYC was immunoprecipitated either with anti-MYC antibodies or unspecific mouse IgG as described in Materials and Methods. The
presence of Rad9 in the IPs was detected by Western blot analysis of the immunoprecipitates with specific anti-Rad9 antibodies. (C)
Immunoprecipitations with anti-MYC antibodies were performed on extracts from nocodazole arrested cells, treated with 150 mg/ml of zeocin for
30 min, expressing Dpb11-MYC in a RAD9 (YFP38) or rad9S11A (YMAG281) background. The presence of Rad9 was detected by Western blot analysis
of the immunoprecipitates with specific anti-Rad9 antibodies. Lower exposure of the crude extracts lanes are shown to allow visualization of both
Rad9 and Dpb11 specific bands.
doi:10.1371/journal.pgen.1001047.g006
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(YMAG149/7B), H2A-S129A (YMAG168), dpb11DCT (YMAG145/20C), dot1D (YMAG150/4A), H2A-S129A dpb11DCT (YMAG155), H2A-S129A dot1D
(YMAG170), dpb11DCT dot1D (YMAG148) and H2A-S129A dpb11DCT dot1D (YMAG157) strains were arrested in M with nocodazole and UV irradiated
(75 J/m
2). After 10 min, samples were collected and analyzed in their total (T), soluble (S) and chromatin-enriched (Ch) fractions; blots were probed
with anti-Rad9 antibodies (left panel). Protein extracts were also prepared from mock and UV treated samples and analyzed by SDS-PAGE and
Western blotting with anti-Rad53 antibodies to monitor checkpoint activation (right panel). The positions of Rad9 and its hyper-phosphorylated
isoform (pRad9) are indicated. p* marks partially phosphorylated Rad9 species.
doi:10.1371/journal.pgen.1001047.g007
Figure 8. Partial checkpoint activation after forced Rad9 dimerization in M phase acts through the Dpb11-dependent checkpoint
pathway. (A) wt (K699), rad9-S11A (YMAG162), rad9DBRCT::GST (YMAG74) and rad9-S11ADBRCT::GST (YFL1177) strains were arrested with nocodazole
and mock or UV irradiated (75 J/m
2). After 10 min, samples were collected and protein extracts were separated by SDS-PAGE. Blots were analyzed
either with anti-Rad53 antibodies or with the F9 Mab to monitor checkpoint activation. (B) UV survival assay. The same strains as in A were cultured
overnight and then diluted and plated on YPD plates, which were irradiated with the indicated UV doses. Cell survival was assayed as described in the
legend to Figure 3.
doi:10.1371/journal.pgen.1001047.g008
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chromatin-bound in unperturbed conditions throughout the cell
cycle, confirming previous suggestions [22] and supporting our
earlier model [14]. According to the current view, Rad9-
chromatin association is controlled by interaction between its
Tudor domain and H3-K79me. Constitutive, dynamic recruit-
ment of Rad9 to chromatin may facilitate the efficiency and speed
of the Rad9-dependent response to genotoxins. After DNA
damage, Rad9 binding to chromatin is further strengthened
through its BRCT domain, which is required to productively
interact with cH2A [22,23]. In this study we found that the BRCT
domain of Rad9, in addition to promoting interaction with cH2A,
has a more general function in modulating Rad9 recruitment. In
fact, the rad9-F1104L and rad9-W1280L mutations, affecting the
folding of the whole BRCT domain [21], alter binding to
chromatin also in the absence of any genotoxic treatment. The
observation that rad9-K1088M cells are defective in Rad9
chromatin recruitment only after c-irradiation may be explained
if such mutation only prevents Rad9-cH2A interaction [22].
In G1 cells, Rad9 binding to chromatin can be achieved by
substituting the BRCT repeats with a heterologous dimerization
domain; such recruitment requires the activity of Dot1 histone
methyl-transferase, indicating that BRCT-mediated dimerization
may be a pre-requisite for constitutive interaction between the
Rad9 Tudor domain and H3-K79me. Given the symmetrical
structure of the histone octamer within the nucleosome core,
dimerization might facilitate the correct orientation and position-
ing of two Rad9 molecules on the nucleosome, allowing
productive interactions with modified histones (Figure 9). Such
hypothesis is supported by structural modeling of a dimeric S.
pombe Crb2 complex on a single nucleosome, where all the
interactions with H4-K20me and cH2A are satisfied without
changing the conformation of the histone core [31].
It is worth noting that dimerization forced by replacement of the
Rad9 BRCT domains with the heterologous GST tag only restores
Rad9 binding to chromatin in G1-, and not in M-arrested cells. In
fact, in cells arrested with nocodazole, we observed that GST-
induced dimerization can rescue Rad9 hyper-phosphorylation and
DNA damage checkpoint activation, but not its stable recruitment
to chromatin. It is possible that in mitosis cell cycle-dependent
phosphorylation of Rad9 may interfere with the chromatin
association of this artificial Rad9 dimer. Alternatively, in
nocodazole-arrested cells the Rad9 BRCT motifs may play
additional roles in modulating Rad9-chromatin interactions.
Several findings indicate that the cellular response to DNA
damage, including the repair mechanisms themselves, are
regulated differently in distinct cell cycle stages. Multiple layers
of cell cycle regulation may modulate the recruitment of critical
checkpoint and repair factors to damaged DNA, as well as
facilitate their reciprocal cross-talk [63–67]. We have previously
shown that Dpb11 is essential for full DNA damage checkpoint
activation in M-arrested cells [50]. Dpb11 is held in proximity to
damaged DNA through its interaction with phosphorylated 9-1-1
complex, leading to Mec1-dependent Rad9 phosphorylation.
Taking advantage of the cdc28-as1 mutation, which allows
conditional turn off of CDK1 kinase activity, we have demon-
strated that CDK1, targeting Rad9, is required for the function of
the Dpb11-dependent branch of the checkpoint response. Indeed,
yeast cells carrying a truncated Rad9 version lacking 9 putative
Cdc28 phosphorylation sites in the N-terminal region, are
checkpoint-defective in M phase, in the absence of the histone-
dependent branch. The Ser11 residue in the Rad9 N-terminal
region is the most relevant Cdc28 target site, since a rad9-S11A
mutation recapitulates the phenotypes observed in rad9DNT cells.
By two-hybrid analysis we showed that Rad9 and Dpb11
specifically interact in M-phase arrested cells, even in the absence of
DNA damage, and this interaction is stimulated by CDK1-
dependent Rad9 phosphorylation. Co-immunoprecipitation exper-
Figure 9. Possible model of the dynamics of Rad9 chromatin
binding and its interaction with Dpb11 to modulate check-
point activation in M phase. Under untreated conditions, Rad9 is
chromatin bound through the interaction of its Tudor domain with H3-
K79me and its BRCT-mediated dimerization. After DNA damage,
activated Rad9 may change its conformation, interacting also with c-
H2A. In M-phase an alternative means of Rad9 recruitment near DNA
lesions involves its interaction with Dpb11. This factor is brought near
the Mec1-Ddc2 complex via its interaction with the 9-1-1 clamp, and it
binds the phosphorylated N-terminal portion of Rad9 leading to full
checkpoint activation.
doi:10.1371/journal.pgen.1001047.g009
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ylation of Rad9-S11 and revealed that it depends upon genotoxic
treatment,althoughwecannotexclude a weak/transient interaction
in untreated conditions. This finding can be explained if activation
of Mec1 by DNA damage facilitates or controls this interaction, e.g
phosphorylating Dpb11 [50], exposing phospho-S11 or stimulating
Rad9-S11 modification by CDK1. The overexpression conditions
typical of the two hybrid system can easily explain why a weak
interaction can be detected also in the absence of DNA damage.
Interestingly, the functional interactions between Dpb11 and Rad9
in budding yeast are reminiscent of similar findings in the distantly
related S. pombe, where histone-independent checkpoint activation is
also modulated by CDK1 [37].
The Dpb11-dependent pathway does not require the histone
modifications modulating Rad9 recruitment to chromatin. We
found that a truncated C-terminal version of Dpb11 does not
affect Rad9 recruitment to chromatin, which is instead abolished
when the histone-dependent pathway is defective. Surprisingly, in
a dot1D H2A-S129A double mutant strain checkpoint activation in
M phase is virtually undistinguishable from that found in wild type
cells, although Rad9 is not stably bound to chromatin. Only when
the dpb11DCT mutation is combined with the dot1D or H2A-S129A
mutation the checkpoint response is turned off. The working
model presented in Figure 9, suggests that Dpb11 may act in M-
phase as an alternative means of Rad9 recruitment. Dpb11 is
located close to sites of DNA damage through its interaction with
the Mec1-phosphorylated 9-1-1 complex; DNA damage leads to
Mec1-dependent phosphorylation of Dpb11 [50], which interacts
with S11-phosphorylated Rad9 (Figure 9). This Dpb11-dependent
localization of Rad9 to sites of DNA damage allows rapid Rad9
hyper-phosphorylation by PIKKs, as suggested by the observation
that the interaction between Rad9 and Dpb11 is induced by
genotoxic agents and hyper-phosphorylated Rad9 is enriched in
the Dpb11-bound population. Subsequently, Rad53 recruitment
via its FHA domains leads to full activation of the checkpoint
response. Unlike Rad9 bound via histone marks, Rad9 complexed
with Dpb11 does not appear to be tightly linked to chromatin,
explaining why the Dpb11-dependent branch for checkpoint
activation seems to act in a chromatin-independent manner.
However, we cannot rule out the possibility that the Rad9-Dpb11
complex can transiently or weakly bind to chromatin.
The model suggested here is in agreement with similar findings
in the distantly related S.pombe fission yeast [37] as well as with
recent in vitro data describing Dpb11 role in checkpoint activation
[68], suggesting that the proposed mechanism can be extended to
other eukaryotic organisms.
Materials and Methods
Strains and plasmids
All of the strains used in this work are derivatives of W303
[MATa ade2-1 trp1-1 can1-100 leu2-3,12 his3-11,15 ura3 rad5-535];
only strains YFP91 and DLY2236 (provided by D. Lydall), are
RAD5
+. All the strains used in this study are listed in Table S1 and
further information regarding strains and plasmids is available
upon request.
Plasmids pMAG11.1 and pFP15 are, respectively, the Rad9
prey and Dpb11 bait plasmids used for the yeast two-hybrid
analysis. They were obtained by amplifying the relevant coding
sequences from genomic DNA and by ligating the resulting
fragments into pJG4-5 and pEG202 [69], respectively.
The plasmid pMAG9, which encodes the Rad9DNT prey, was
obtained cloning the rad9DNT sequence, amplified from the yeast
strain DLY2236, into pJG4-5.
Gene deletions were obtained by PCR-mediated gene replace-
ment [70].
The YNOV15 (rad9-F1140L) and YNOV31 (rad9-W1280L)
strains were obtained from YFL871. The kanMX4 and KlURA3
CORE cassettes, amplified from pCORE [71], were integrated in
a K699 strain at position 1941 of the RAD9 gene. Subsequently,
the CORE cassette was replaced with the C-terminus of the rad9-
F1104L or rad9-W1280L alleles, amplified respectively from
pFL75.5 or pFL69.1, thus restoring the full-length RAD9 open
reading frame bearing the intended mutation. RAD9 site-specific
mutations on plasmids pFL75.5 and pFL69.1 were obtained by
PCR with mutagenic oligonucleotides on the pFL36.1 plasmid
[50]. Recombination events were selected on 5-fluoroorotic acid
plates, and the strains were verified by sequencing.
The rad9DBRCT::13MYC and the rad9DBRCT::GST mutant
alleles were obtained by introducing the 13-MYC or GST tags at
the 984 aa, using the one-step PCR method [70], thus eliminating
the whole Rad9 BRCT domain.
The cdc28-as1 mutant allele was obtained by ClaI-directed
integration of plasmid pVF6 [72] at the CDC28 locus into the
desired background. Plasmid pop-out events were selected on 5-
fluoroorotic acid plates, and the presence of the cdc28-as1 mutation
was verified by assessing sensitivity to 1NMPP1 on plate.
Strains encoding the rad9-S11A mutant allele were obtained by
MscI-directed integration of pRS306-NTRAD9
cdk1 into the
desired background. The transversion TCT-GCT causing the
rad9-S11A mutation and the reversion GCT to ACT generating
the rad9-S11T allele were produced by site- directed mutagenesis
(Stratagene) of pGEMTeasyRAD9, containing a 2547 bp frag-
ment from position -445 to position +2102 within the RAD9 ORF.
The 1.8 Kb BamHI-MscI fragment from the pGEMTeasyRAD9
vector was swapped with the equivalent fragment from an existing
6.3 Kb pRS306-NTRAD9 integrative vector, containing a
BamHI-SpeI RAD9 fragment from position 2445 to position
1478 within the RAD9 ORF and the presence of the mutation
verified by sequencing. Plasmid pop-out events were selected on 5-
fluoroorotic acid plates, and the rad9-S11A mutation was
confirmed by PCR sequencing.
The dpb11DCT mutant allele was obtained by introducing a
premature stop codon at the 583 aa and the HPH cassette after the
codon with the one step PCR method previously described [73],
thus mimicking the dpb11-1 mutation [74].
Strain YFL921 was obtained by using the one-step PCR
strategy described in Longtine 1998, using pFA6-FKBP2x-13MYC-
KanMX6, as template. This plasmid was generated by cloning in
PacI-linearized pFA6-13MYC-KanMX6 the FKBP2x sequence
amplified from pC4M-FV2E (ARGENT Regulated Homodimer-
ization kit, ARIAD Pharmaceutical).
The yeast two hybrid was performed using the B42/lexA system
with strain EGY42 (MATa his3 ura3 trp1 6lexAOP-LEU2; lex- AOP-
lacZ reporter on plasmid pBH18-34) as the host strain [69].
Chromatin binding
To analyze chromatin binding of proteins, yeast extracts were
prepared from G1- or M-arrested cells following published
procedures [22].
Cell cycle blocks and DNA damage treatments
Cells were grown in YPD medium at 28uC (25uC in the
experiments with strains harboring the dpb11DCT mutation) to a
concentration of 6610
6 cells/ml and arrested in G1 or M with a-
factor (20 mg/ml) or nocodazole (20 mg/ml), respectively. 50 ml of
cultures were centrifuged, resuspended in 500 ml of fresh YPD and
plated on a Petri dish (14 cm diameter). Plates were quickly
Rad9 Chromatin Binding and Checkpoint Activation
PLoS Genetics | www.plosgenetics.org 11 August 2010 | Volume 6 | Issue 8 | e1001047irradiated with a Stratalinker at 75 J/m
2 and cells resuspended in
50 ml of YPD plus a-factor or nocodazole. A 25 ml sample was
taken 10 min after the treatment and processed for protein
extraction with trichloroacetic acid (TCA) [75]. For analysis of the
double-strand breaks (DSBs) checkpoint response, cells arrested at
the proper cell cycle phase were treated with 150 mg/ml of zeocin.
Samples were taken 45 min after treatment and processed for
protein extraction.
FKBP dimerization
To analyze FKBP-driven (FK506 binding protein) dimerization,
overnight cell cultures were diluted at a concentration of
1610
6 cells/ml and treated for 6 h with 1 mM AP20187
(ARGENT Regulated Homodimerization kit, ARIAD Pharma-
ceutical). UV sensitivity assays or chromatin binding analysis were
performed as described elsewhere in this section.
Inactivation of the Cdc28 kinase activity
Exponentially growing cells in a cdc28-as1 background were
harvested at a concentration of 4610
6 cells/ml and blocked in M
phase as described above. To selectively inhibit Cdc28 activity
[56], the ATP analogue 1NMPP1 was then added to a
concentration of 5 mM to half of the cultures; after 2 h of
incubation at 28uC, cells were either mock- or UV-irradiated and
protein extracts were prepared.
SDS-PAGE and western blotting
TCA protein extracts or chromatin binding samples were
separated by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) in 10% acrylamide gels. For the analysis of
Rad9 phosphorylation, NuPAGE Tris-acetate 3% to 8% gels were
used following the manufacturer’s instructions. Western blotting
was performed with anti-Rad9 (D. Stern), anti-Rad53 (C.
Santocanale), with anti-phosphorylated Rad53 F9 Mab antibodies
[76] anti-ORC2 (Abcam) and anti-tubulin (ML. Carbone), using
standard techniques.
UV–sensitivity assay
To assess cell survival after UV irradiation, serials dilutions of
overnight cultures were spotted onto YPD plates, which were
either irradiated with different UV doses or mock-treated. For
survival curves, yeast strains were cultured overnight to exponen-
tially growing phase. Cells were diluted and approximately 500
cells/plate were plated, and then either irradiated with various UV
doses or mock-treated. After 3 days, the total number of colonies
formed on each plate was counted.
Yeast two-hybrid analysis
Protein interaction between Rad9 and Dpb11 in the G1 and M
phase of the cell cycle was assessed by measuring b-galactosidase
activity with ortho-Nitrophenyl-b-galactoside (ONPG) assay.
Briefly, cells expressing Rad9 bait and/or Dpb11 prey were
cultured overnight in yeast synthetic media (-Ura, -His, -Trp) with
2% (w/v) raffinose to a concentration of 5610
6 cells/ml. Cultures
were centrifuged and cells resuspended in YP plus raffinose and
arrested in G1 or M phases, as described above. Galactose to a 2%
w/v final concentration was added to the medium to induce prey
expression. A 15 ml sample was taken after 1 h of galactose
induction, centrifuged and resuspended in 250 ml of breaking
buffer (100 mM Tris HCl at pH 8.0, Glycerol 10%; DTT 1 mM,
1 tablet of complete Roche antiproteolytic cocktail. Cells were
lysed by using a FastPrep cell disruptor; the optical density (OD) of
protein extract at 600 nm was determined using the Bio-Rad
protein assay reagent. 1 ml of Z buffer (60 mM Na2HPO4,
40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, and 50 mM b-
mercaptoethanol at pH 7.0) plus ONPG 4 mg/ml was aliquoted
in a small glass tube for each sample. 20 ml of protein extract was
added to each tube and incubated at 37uC until a yellow color
developed. The reaction was stopped by adding 400 ml of 1 M
NaCO3 and the OD at 420 nm of each sample was measured. b -
Galactosidase activity was calculated by using the formula units
=10
3 OD420/(OD600 x reaction time in min).
Rad9-Dpb11-MYC immunoprecipitation
1.5 l cultures of strains YFP38 and YMAG281 expressing,
respectively, the tagged Dpb11-MYC fusion protein under the
control of the endogenous DPB11 promoter in a wild-type or
rad9S11A mutant background were grown in YPD medium at a
cell density of 1610
7 cells/ml. Cells were then arrested in M phase
by addition of 10 mg/ml of nocodazole and were either mock
treated or treated with 150 mg/ml of zeocin for 30 min. Cells were
washed twice with pre-cooled ddH2O and once in 26lysis buffer
(300 mM KCl, 100 mM Hepes (pH 7.5), 20% glycerol, 8 mM b-
mercaptethanol, 2 mM EDTA, 0.1% Tween20, 0.01% NP-40).
Resuspended cells were frozen as droplets in liquid nitrogen.
Aliquots of frozen cells were manually ground in a mortar in liquid
nitrogen. One volume of 26 lysis buffer, containing a protein
inhibitor cocktail (2.8 mM leupeptin, 8 mM pepstatin A, 4 mM
PMSF, 50 mM benzamidine, 25 mM antipain, 4 mM chymostatin
in ethanol) and phosphatase inhibitors (2 mM sodium fluoride,
1.2 mM b-glycerophosphate, 0.04 mM sodium vanadate, 2 mM
EGTA, 10 mM sodium pyrophosphate), was added. Cell extract
was clarified by a low speed centrifugation followed by additional
centrifugation for 1 h at 42.000 rpm in a Beckman Sw55Ti rotor.
The clarified crude extract (Ext) was adjusted to 10 mg/ml in the
various immunoprecipitation experiments. 1 ml of Ext was pre-
cleared by incubation with 40 ml of 50% (v/v beads/16 lysis
buffer) Protein G slurry for 1 hour at 4uC on a rotating wheel. Pre-
cleared supernatants were incubated with either 20 mg of the anti-
myc Mab 9E11 or 20 mg of unspecific mouse IgG. Samples were
incubated for 2 h at 4uC on a rotating wheel and centrifuged at
14.000 rpm for 15 min at 4uC. 40 ml of 50% protein G slurry were
added to the supernatants, incubated on a rotating wheel for 2 h at
4uC and recovered by centrifugation. Immunoprecipitated
Dpb11-MYC samples were washed four times with 1 ml of lysis
buffer containing protease and phosphatase inhibitors. Beads were
finally resuspended in 40 mlo f3 6Laemmli buffer (IP), boiled for
5 min and released proteins separated on 6.5% (80/1 acrylamide/
bisacrylamide) SDS-PAGE gels. After blotting, Rad9 was
visualized with the NLO5 Rad9 polyclonal antibody [13] or the
9E11 Mab (Abcam).
Supporting Information
Figure S1 (A) wt (K699) cells were arrested in G1 with a-factor
and either mock or UV irradiated (75 J/m
2). 10 min after
irradiation, samples were collected and analyzed in their total
(T), soluble (S) and chromatin-enriched (Ch) fractions. Blots were
probed with anti Rad9 polyclonal antibodies. After UV irradiation
the hyper-phosphorylated Rad9 isoform migrates and it is detected
on Western blots probed with anti-Rad9 antibodies near to an
aspecific protein species (mostly present in the supernatant
fraction) [50]. Such band was omitted in the Western blots shown
in Figure 1, Figure 2, and Figure 7 for clarity. The positions of
Rad9 and its hyper-phosphorylated isoform (pRad9) are indicated;
* marks the background protein species unrelated to Rad9. (B)
The Western blots in which the presence of Rad9 was analyzed in
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were controlled for proper fractionation of control proteins, known
to remain in the soluble fraction (Tubulin) or to bind to chromatin
(Orc2). The blots in S1 Panel B show the results obtained with the
same protein samples analyzed in Figure 1A. (C) Quantitative
analysis of the percentage of hyper-phosphorylated and hypo-
phosphorylated Rad9 isoforms in the total (T), soluble (S) and
chromatin-enriched (Ch) fractions in a-factor and nocodazole
arrested wild-type cells. Quantification was obtained with a
Versadoc (Biorad) after incubation with fluorescent secondary
antibodies, and error bars were obtained from 4 independent
experiments. The percentages of hyper- and hypo- phosphorylated
isoforms were calculated respectively to the total amount of Rad9.
Found at: doi:10.1371/journal.pgen.1001047.s001 (1.16 MB TIF)
Figure S2 (A) The histograms show the M/G1 ratio increase in
b-galactosidase activity, when the interaction between Dpb11/
Rad9 or the positive controls p53 and SV40-TAg was measured
by two-hybrid analysis in nocodazole (M) or a-factor (G1) arrested
cells. Error bars were obtained from three independent two-hybrid
experiments. (B) Amino acid sequence of the Rad9 ORF; the basic
CDK1 (S/T-P) and PIKK (S/T-Q) consensus phosphorylation
sites are shown in black or gray, respectively. (C) wt (K699) and
rad9-S11A (YMAG162) strains were arrested in M with nocodazole
and samples were collected to prepare protein extracts. Rad9
phosphorylation was analyzed by SDS-PAGE and Western
blotting with anti-Rad9 antibodies.
Found at: doi:10.1371/journal.pgen.1001047.s002 (0.77 MB TIF)
Figure S3 wt (YMAG149/7B), H2A-S129A (YMAG168),
dpb11DCT (YMAG145/20C), H2A-S129A dpb11DCT
(YMAG155), dot1D (YMAG150/4A), H2A-S129A dot1D
(YMAG170), dpb11DCT dot1D (YMAG148) and H2A-S129A
dpb11DCT dot1D (YMAG157) strains were arrested in M with
nocodazole and treated with zeocin (150 mg/ml). After 45 min,
samples were collected and protein extracts were analyzed by
SDS-PAGE and Western blotting with anti Rad53 antibodies to
monitor checkpoint activation.
Found at: doi:10.1371/journal.pgen.1001047.s003 (0.76 MB TIF)
Table S1 Strains used in this study. All of the strains used in this
work are derivatives of W303 [MATa ade2-1 trp1-1 can1-100 leu2-
3,12 his3-11,15 ura3 rad5-535]; only strains YFP91 and DLY2236
(provided by D. Lydall), are RAD5
+.
Found at: doi:10.1371/journal.pgen.1001047.s004 (0.06 MB
DOC)
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